Skip to content
Supercharge Co-Development of Therapeutics & Companion Diagnostics
Returning September 3 - 6, 2024 | Boston, MA
Get updates for the 2024 meeting
View upcoming events in the Precision Oncology Series
Menu
Home
About
About 2023 Event
Hanson Wade
What’s On
2023 Full Event Guide
2023 Expert Speakers
Partnership
Partnership Opportunities
2023 Partners
Take Part
Register Interest
Contact us
Leveraging Broad Adoption of the Signatera MRD Assay to Accelerate Clinical Development
Time:
9:40 am
day:
Day 2 AM
Speakers:
John Simmons
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
